郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Synthesis and pharmacological evaluation of novel octahydro-1H-pyrido[1,2-a]pyrazine as mu-opioid receptor antagonists.

期刊：Journal of medicinal chemistry发表年份：2006作者：Bertrand Le Bourdonnec; Allan J Goodman; Thomas M Graczyk; Serge Belanger; Pamela R Seida; Robert N DeHaven; Roland E Dolle
阅读更多 →

药效评价Pharmacological profile of antipsychotics at monoamine receptors: atypicality beyond 5-HT2A receptor blockade.

期刊：CNS & neurological disorders drug targets发表年份：2006作者：Martyn D Wood; Claire Scott; Kirsten Clarke; Katherine J Cato; Nisha Patel; Jennie Heath; Angela Worby; Laurie Gordon; Lorraine Campbell; Graham Riley; Ceri H Davies; Andrew Gribble; Declan N C Jones
阅读更多 →

药效评价Design and synthesis of new tetrazolyl- and carboxy-biphenylylmethyl-quinazolin-4-one derivatives as angiotensin II AT1 receptor antagonists.

期刊：Journal of medicinal chemistry发表年份：2006作者：Mohamed A H Ismail; Stewart Barker; Dalal A Abou el-Ella; Khaled A M Abouzid; Rabab A Toubar; Matthew H Todd
阅读更多 →

药效评价Pharmacological promotion of inclusion formation: a therapeutic approach for Huntington's and Parkinson's diseases.

期刊：Proceedings of the National Academy of Sciences of the United States of America发表年份：2006作者：Ruth A Bodner; Tiago Fleming Outeiro; Stephen Altmann; Michele M Maxwell; Stephanie H Cho; Bradley T Hyman; Pamela J McLean; Anne B Young; David E Housman; Aleksey G Kazantsev
阅读更多 →